ERBB2 and breast cancer: Increased levels of TILs in women receiving neoadjuvant or adjuvant chemotherapy are associated with improved recurrence‐free and overall survival (OS) in HER2+ BC and TNBC.8, 9, 10, 11, 12, 13, 14, 15, 16